An attenuated strain of human cytomegalovirus for the establishment of a subviral particle vaccine

HIGHLIGHTS

• who: Steffi Krauter and collaborators from the Institute for Virology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany have published the research: An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine, in the Journal: Vaccines 2022, 1326 of /2022/
• what: The work focused on providing a final seed virus strain for DB vaccine production. Depending on the experimental design of the experiment, the authors used a double or triple labelling procedure, where always a standard dimethyl group was used to label the light sample.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.